AbbVie at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

AbbVie at ASHG 2026 in Montréal: 2 presentations (1 platform talk, 1 poster).

Organization	ASHG 2026 Attendance
AbbVie St Laurent, Quebec	1 PhD Student · 1 Senior Scientist
abbvie.ca\|LinkedIn Public company~57,000 people AbbVie discovers and delivers innovative medicines and solutions. It develops therapies for patients across immunology, oncology and neuroscience. AbbVie completed its acquisition of Apogee Therapeutics, which is now part of the company, expanding its immunology pipeline. › AbbVie completed its acquisition of Apogee Therapeutics, which is now part of the company, expanding its immunology pipeline. 2026-09 · source The FDA accepted AbbVie's supplemental application for BOTOX Cosmetic to treat masseter muscle prominence. 2026-08 · source RINVOQ became the first systemic medication approved in the EU for adult and adolescent non-segmental vitiligo. 2026-07 · source Source: company newsroom Q2 2026 revenue $16.99B, up 10.2% › Adjusted diluted EPS guidance is $13.87-$14.07, reflecting strong operational growth across its portfolio. · 2026-07-31 “Delivers Second-Quarter Net Revenues of $16.990 Billion, an Increase of 10.2 Percent on a Reported Basis or 9.5 Percent on an Operational Basis” Source: results release Currently hiring: 1,607 open roles › Source: careers page	Talk Thu Oct 22 9:00 am Part of From Labels to Landscapes: Leveraging Local Ancestry and the Ancestry Continuum to Maximize Cross-Ancestry Association Betanfer: Estimation of linkage disequilibrium from GWAS summary statistics enables large-scale cross-biobank fine mapping Room 710A/Level 7 Collaborators: Argonne National Laboratory, University of Pennsylvania +6 more Genome-wide association studyGenetic mappingStatistical genetics Poster Thu Oct 22 4:15 pm Part of Cancer Poster Thursday Session Omics-driven causal insights into immune-related adverse events in colorectal cancer Exhibit & Poster Hall · Board 1047T CancerEpidemiologyImmune systemMulti-omics

Organization

ASHG 2026 Attendance

AbbVie

St Laurent, Quebec

1 PhD Student · 1 Senior Scientist

abbvie.ca|LinkedIn

Public company~57,000 people

AbbVie discovers and delivers innovative medicines and solutions. It develops therapies for patients across immunology, oncology and neuroscience.

AbbVie completed its acquisition of Apogee Therapeutics, which is now part of the company, expanding its immunology pipeline.

›

AbbVie completed its acquisition of Apogee Therapeutics, which is now part of the company, expanding its immunology pipeline.

2026-09 · source

The FDA accepted AbbVie's supplemental application for BOTOX Cosmetic to treat masseter muscle prominence.

2026-08 · source

RINVOQ became the first systemic medication approved in the EU for adult and adolescent non-segmental vitiligo.

2026-07 · source

Source: company newsroom

Q2 2026 revenue $16.99B, up 10.2%

›

Adjusted diluted EPS guidance is $13.87-$14.07, reflecting strong operational growth across its portfolio. · 2026-07-31

“Delivers Second-Quarter Net Revenues of $16.990 Billion, an Increase of 10.2 Percent on a Reported Basis or 9.5 Percent on an Operational Basis”

Source: results release

Currently hiring: 1,607 open roles

›

Source: careers page

Talk

Thu Oct 22
9:00 am

Part of From Labels to Landscapes: Leveraging Local Ancestry and the Ancestry Continuum to Maximize Cross-Ancestry Association

Betanfer: Estimation of linkage disequilibrium from GWAS summary statistics enables large-scale cross-biobank fine mapping

Room 710A/Level 7

Collaborators: Argonne National Laboratory, University of Pennsylvania +6 more

Genome-wide association studyGenetic mappingStatistical genetics

Poster

Thu Oct 22
4:15 pm

Part of Cancer Poster Thursday Session

Omics-driven causal insights into immune-related adverse events in colorectal cancer

Exhibit & Poster Hall · Board 1047T

CancerEpidemiologyImmune systemMulti-omics

Instantly find 20 buyers from AbbVie

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction